✦ LIBER ✦

Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer

✍ Scribed by Jones, S. E.; Savin, M. A.; Holmes, F. A.; O'Shaughnessy, J. A.; Blum, J. L.; Vukelja, S.; McIntyre, K. J.; Pippen, J. E.; Bordelon, J. H.; Kirby, R.; Sandbach, J.; Hyman, W. J.; Khandelwal, P.; Negron, A. G.; Richards, D. A.; Anthony, S. P.; Mennel, R. G.; Boehm, K. A.; Meyer, W. G.; Asmar, L.

Book ID: 124049370
Publisher: American Society of Clinical Oncology
Year: 2006
Tongue: English
Weight: 372 KB
Volume: 24
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2006.06.5391

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3–59 Phase III Trial Comparing Doxorubic

3–59 Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclosphosphamide As Adjuvant Therapy for Operable Breast Cancer

✍ Denlinger, C.S.; Goldstein, L.J. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Adjuvant docetaxel plus doxorubicin and

Adjuvant docetaxel plus doxorubicin and cyclophosphamide increases survival compared with fluorouracil plus doxorubicin and cyclophosphamide in women with operable node-positive breast cancer

✍ Vivek Roy; Edith A. Perez 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 74 KB

PCN91 LONG TERM COST-EFFECTIVENESS OF DO

PCN91 LONG TERM COST-EFFECTIVENESS OF DOCETAXEL PLUS CYCLOPHOSPHAMIDE COMPARED TO DOXORUBICIN PLUS CYCLOPHOSPHAMIDE AS ADJUVANT TREATMENT FOR WOMEN WITH OPERABLE BREAST CANCER

✍ D Jackson; JM Lee; J Adams; A Gordois 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

PCN50 COST-EFFECTIVENESS OF DOCETAXEL PL

PCN50 COST-EFFECTIVENESS OF DOCETAXEL PLUS CYCLOPHOSPHAMIDE VERSUS DOXORUBICIN PLUS CYCLOPHOSPHAMIDE IN THE ADJUVANT TREATMENT OF OPERABLE BREAST CANCER

✍ S Jones; L Chen; M Tangirala; L Asmar; P Airia; MF Thompson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

S-1 combined with docetaxel following do

S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial

✍ Moon, Yong; Lee, Soohyeon; Park, Byeong-Woo; Kim, Eun-Kyung; Kim, Seung; Koo, Ja 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 185 KB

Phase III trial of liposomal doxorubicin

Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer

✍ Chan, S. 📂 Article 📅 2004 🏛 Oxford University Press 🌐 English ⚖ 91 KB